PDF-ikon Printikon

ImmuView® S. pneumoniae and
L. pneumophila Antigen Test

ImmuView® S. pneumoniae and L. pneumophila Antigen Test is the one rapid test that detects pneumococcus and Legionella with higher sensitivity and specificity and offers broader detection of L. pneumophila serogroup 1 and non-serogroup 1 to the benefit of patients.

ImmuView® is based on SSI Diagnostica’s long tradition of premium quality antibody production.

Immuview s. pneumoniae and l. pneumophila urinary antigen test

Product Description

ImmuView® S. pneumoniae and L. pneumophila Antigen Test makes it possible to readily distinguish between S. pneumoniae and L. pneumophila in patients with presumed pneumococcal pneumonia and Legionella infection (Legionnaire’s disease) and thereby allows clinicians to initiate the correct antibiotic treatment to improve the outcome for the patient.

S. pneumoniae is the leading cause of community-acquired pneumonia and L. pneumophila causes costly hospital and ICU admissions. It is difficult to clinically distinguish between the two bacteria. Due to different treatment of the diseases, guidelines recommend double testing.1,2  

The first of its kind

ImmuView® S. pneumoniae and L. pneumophila Antigen Test is the first of its kind to provide diagnostics for both S. pneumoniae and L. pneumophila in one test.

Improve your diagnostics with ImmuView® S. pneumoniae and L. pneumophila Antigen Test and benefit from several factors:

•  Rapid and simple detection of both pneumococcus and Legionella in one test
•  Initiate the correct antibiotic treatment to improve patient outcome
•  Higher sensitivity and specificity
•  Broader detection of L. pneumophila serogroup 1 and non-serogroup 1
•  Testing for S. pneumoniae and L. pneumophila is recommended in guidelines in several countries.1,2 
•  Results in 15 minutes 

Sensitivity & Specificity

Urine samples:
The clinical sensitivity and specificity were obtained by testing
retrospective urine samples.

Urine ImmuView® Sensitivity
Other Rapid Tests Sensitivity
S. pneumoniae
85% (60/71) 78% (55/71) 
 L. pneumophila SGI
89% (88/99) 72% (71/99) 
 Combined 73% (161/220) 58% (127/220) 
 L. pneumophila non-SGI
26% (13/50)  2% (1/50) 

Specificity of L. pneumophila was 100% (0/76) and S. pneumoniae
was 99% (1/76).

Cerebral Fluid (CSF) Samples:

Sensitivity was tested with culture positive samples and spiked samples. Specificity was tested with culture positive samples for other bacteria, culture negative and donor samples.


CSF ImmuView® Sensitivity
ImmuView® Specificity
S. pneumoniae
100% (27/27) 100% (205/205)

The specificity of L. pneumophila was 100% (0/205). The sensitivity was not examined.

Storage and Shelf Life

Store at room temperature. Expiry date is printed on the package.

Article
number
Product  Number
of tests
Packing
95389 ImmuView® S. pnemoniae and L. pneumophila Antigen Test 22 1 box

Guidelines

The following countries have national guidelines recommending to test for Pneumococcus and Legionella. Download or read the guidelines below.

References 

  1. NICE National Institute for Health and Care Excellence. Pneumonia in adults: diagnosis and Management. www.nice.org.uk/guidance/cg191 (published December 3, 2014).
  2. R. Menéndez et al. Community Acquired Pneumonia. New Guidelines of the Spanish Society of Chest Diseases and Thoracic Surgery (SEPAR). Arch Bronconeumol. 2010;46(10):543–558
  3. C. S. Jørgensen, S. A. Uldumb, J. F. Sørensenc, I. C. Skovsted, S. Otte, and P. L. Elverdal. Evaluation of a new lateral flow test for detection of Streptococcus pneumoniae and Legionella pneumophila urinary antigen. Journal of Microbiological Methods 116 (2015) 33-36

Webshop

Find the product in our webshop

SHOP.SSIDIAGNOSTICA.COM

Shopping